VP
venBio Partners Portfolio holdings
AUM
$115M
This Quarter Return
-1.57%
1 Year Return
-33.99%
3 Year Return
+221.07%
5 Year Return
+224.54%
10 Year Return
–
AUM
$211M
AUM Growth
+$211M
(-6.5%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Akero Therapeutics
AKRO
$3.74B
| $90M | 42.68% | 3,954,858 | – | – |
|
|
TPTX
2
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $50.4M | 23.91% | 1,340,265 | – | – |
|
3
Precision BioSciences
DTIL
$57.8M
| $35.8M | 16.98% | 4,265,141 | – | – |
|
4
Apellis Pharmaceuticals
APLS
$3.48B
| $24.1M | 11.43% | 1,000,000 | – | – |
|
5
VYNE Therapeutics
VYNE
$8.16M
| $6.55M | 3.11% | 1,461,552 | – | – |
|
|
VRNA
6
Verona Pharma
VRNA
$9.16B
| $4M | 1.9% | 875,000 | – | – |
|